
On Thursday, Lakeland Financial (LKFN) Director Melinda Jo Truex purchased 8,309 shares at $60.11 each, totaling $499,454, while Lucid Diagnostics (LUCD) Director Dennis Matheis bought 350,000 shares at $1.31 each, investing $457,607. LKFN is up 2.5% on Tuesday, while LUCD is down 4.4%; Matheis is up approximately 30% on his purchase based on Tuesday's high.
Significant insider buying activity has been reported at Lakeland Financial (LKFN) and Lucid Diagnostics (LUCD). At Lakeland Financial, Director Melinda Jo Truex executed a $499,454 purchase of 8,309 shares at $60.11 per share, marking her first declared insider purchase in the past year; LKFN's stock subsequently traded up approximately 2.5% on Tuesday. Concurrently, Lucid Diagnostics saw Director Dennis Matheis invest $457,607 by acquiring 350,000 shares at $1.31 each. This was Matheis's second purchase in the last twelve months, and despite LUCD trading down 4.4% on Tuesday, his recent investment showed an unrealized gain of about 30.0% based on the day's trading high of $1.70. The per-ticker sentiment for LKFN is notably positive (0.7), while LUCD's is more neutral (0.4), with the overall news theme centering on insider transactions. Such insider purchases are often interpreted as signals of management's confidence in their respective company's prospects, although the reported market impact score of 0.3 suggests these specific activities had limited immediate influence on broader market sentiment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment